超选择性肾动脉栓塞治疗微创经皮肾镜取石术后并发出血  

Hyperselective renal arterial transcatheter embolization in management of intractable hemorrhage after MPCNL

作　　者：丁见[1] 齐琳[1] 申鹏飞[1] 

机构地区：[1]中南大学湘雅医院泌尿外科,湖南长沙410008

出　　处：《中国现代医学杂志》2011年第19期2325-2327,共3页China Journal of Modern Medicine

摘　　要：目的探讨超选择性肾动脉栓塞治疗微创经皮肾镜取石术后继发出血的临床价值。方法回顾和分析该院2005年1月～2010年1月应用微创经皮肾镜取石术(MPCNL)治疗结石患者4 832例,术后并发出血而行高选择性肾动脉栓塞治疗7例的临床资料。结果 7例中6例一次性治愈,1例2 d后再次行栓塞治疗治愈。术后无1例发生并发症,无明显肾功能损害。结论超选择性肾动脉栓塞是MPCNL术后出血治疗的首选方法,其安全性高,疗效肯定。【Objective】 To study the experience of highly selective renal arterial transcatheter embolization in the management of intractable hemorrhage after minimally invasive percutaneous nephrolithotomy（MPCNL）.【Methods】 From Jan 2005 to Jan 2010,2438 cases of MPCNL,7 cases of intractable bleeding were treated with highly selective renal arterial transcatheter embolization.【Results】 In 7 cases,6 cases were successfully with first treated of highly selective renal arterial transcatheter embolization,1 healed after second time.Bleeding was controlled thoroughly.There were no embolization syndromes and renal functional lesion happened.【Conclusions】 In this case report,we performed transcatheter embolization on our patient instead,showing it to be a successful therapy without complications.Intractable hemorrhage after MPCNL benefits from highly selective renal arterial transcatheter embolization.This interventional procedure is suggested as an right therapeutic approach to intractable hemorrhage after MPCNL.

关 键 词：出血 栓塞 微创经皮肾镜取石术 

分 类 号：R692.4[医药卫生—泌尿科学]